|
Unaudited Condensed Consolidated Balance Sheets as of March 31, 2014 and December 31, 2013
|
1 |
|
Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2014 and 2013
|
2 |
|
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2014 and 2013
|
3 |
|
Unaudited Notes to the Condensed Consolidated Financial Statements
|
4 |
|
March 31,
2014 |
December 31, 2013
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash and cash equivalents
|
166,326 | 269,548 | ||||||
|
Accounts receivable, less allowance for doubtful accounts of
|
||||||||
|
$212,760 and $188,069
|
2,321,760 | 3,016,705 | ||||||
|
Inventories
|
986,288 | 918,553 | ||||||
|
Prepaid expenses and other current assets
|
598,117 | 445,991 | ||||||
|
Deferred costs
|
210,000 | 154,693 | ||||||
|
TOTAL CURRENT ASSETS
|
4,282,491 | 4,805,490 | ||||||
|
Property and equipment, net of accumulated depreciation and
|
||||||||
|
amortization of $8,306,728 and $8,174,612
|
1,714,783 | 1,419,031 | ||||||
|
Patents, net of acummulated amortization of $16,086 and $13,746
|
257,379 | 253,602 | ||||||
|
Other non-current assets
|
96,246 | 90,640 | ||||||
|
TOTAL ASSETS
|
$ | 6,350,899 | $ | 6,568,763 | ||||
|
LIABILITIES AND STOCKHOLDERS’ DEFICIT
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable
|
$ | 1,826,390 | $ | 1,969,482 | ||||
|
Accrued expenses
|
777,420 | 985,142 | ||||||
|
Deferred revenue
|
277,384 | 272,572 | ||||||
|
Line of credit
|
960,926 | 1,670,150 | ||||||
|
Long-term debt - current portion
|
800,000 | 800,004 | ||||||
|
TOTAL CURRENT LIABILITIES
|
4,642,119 | 5,697,350 | ||||||
|
Long-term debt, net of current portion
|
2,384,819 | 1,266,656 | ||||||
|
Deferred rent
|
160,368 | 169,604 | ||||||
|
TOTAL LIABILITIES
|
7,187,306 | 7,133,610 | ||||||
|
COMMITMENTS AND CONTINGENCIES
|
||||||||
|
REDEEMABLE
PREFERRED STOCK
|
||||||||
|
Redeemable preferred stock - Series B-2, $0.00002 par value;
|
||||||||
|
14,000,000 shares authorized; 13,046,530 shares issed and
|
||||||||
|
outstanding at March 31, 2014 and December 31, 2013;
|
||||||||
|
liquidation preference of $2,160,000 as of March 31, 2014
|
||||||||
|
and December 31, 2013
|
2,160,000 | 2,160,000 | ||||||
|
Redeemable preferred stock - Series B-1, $0.00002 par value;
|
||||||||
|
35,000,000 shares authorized; 32,864,988 shares issed and
|
||||||||
|
outstanding at March 31, 2014 and December 31, 2013;
|
||||||||
|
liquidation preference of $5,569,038 as of March 31, 2014
|
||||||||
|
and December 31, 2013
|
5,569,038 | 5,569,038 | ||||||
|
Redeemable preferred stock - Series B, $0.00002 par value;
|
||||||||
|
15,000,000 shares authorized; 14,243,934 shares issed and
|
||||||||
|
outstanding at March 31, 2014 and December 31, 2013;
|
||||||||
|
liquidation preference of $10,881,545 as of March 31, 2014
|
||||||||
|
and December 31, 2013
|
10,923,252 | 10,923,252 | ||||||
|
Preferred stock - Series A, $0.00002 par value 3,000,000 shares
|
||||||||
|
authorized; 2,903,207 shares issued and outstanding at March
|
||||||||
|
31, 2014 and December 31, 2013; liquidation preference of
|
||||||||
|
$621,286 as of March 31, 2014 and December 31, 2013
|
664,891 | 664,891 | ||||||
| STOCKHOLDERS’ DEFICIT | ||||||||
|
Common stock, $0.00002 par value; 150,000,000 shares
|
||||||||
|
authorized; 20,544,090 and 19,872,590 shares issued and
|
||||||||
|
outstanding at March 31, 2014 and Decmber 31, 2013
|
480 | 480 | ||||||
|
Treasury stock - common, at cost, 671500 shares at March
|
||||||||
|
31, 2014 and December 31, 2013
|
(66,001 | ) | (66,001 | ) | ||||
|
Additional paid-in capital
|
4,513,607 | 4,507,591 | ||||||
|
Accumulated deficit
|
(24,601,674 | ) | (24,324,098 | ) | ||||
|
TOTAL
REDEEMABLE PREFERRED STOCK STOCKHOLDERS’ DEFICIT
|
(836,407 | ) | (564,847 | ) | ||||
|
TOTAL
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
|
$ | 6,350,899 | $ | 6,568,763 | ||||
| Page 1 |
|
|
||||||||
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
Revenue
|
$ | 2,844,509 | $ | 3,374,277 | ||||
|
Cost of revenue
|
1,128,858 | 1,157,939 | ||||||
|
Gross profit
|
1,715,651 | 2,216,338 | ||||||
|
Operating expenses (income):
|
||||||||
|
Sales and marketing
|
201,997 | 239,931 | ||||||
|
Research and development
|
659,821 | 831,269 | ||||||
|
General and administrative
|
1,078,107 | 1,062,869 | ||||||
|
Gain on sale of monitoring equipment
|
(37,835 | ) | (74,564 | ) | ||||
|
Total operating expenses
|
1,902,090 | 2,059,505 | ||||||
|
Operating (loss) income
|
(186,439 | ) | 156,833 | |||||
|
Interest expense
|
91,135 | 42,724 | ||||||
|
Net (loss) income
|
$ | (277,574 | ) | $ | 114,109 | |||
| Page 2 |
|
Three Months Ended
|
||||||||
|
March 31,
|
||||||||
|
2014
|
2013
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net (loss) income
|
$ | (277,574 | ) | $ | 114,109 | |||
|
Adjustments to reconcile net income (loss) to net cash
|
||||||||
|
used in operating activities:
|
||||||||
|
Provision for bad debt
|
30,000 | 30,000 | ||||||
|
Depreciation and amortization
|
202,954 | 153,218 | ||||||
|
Stock-based compensation
|
6,016 | 14,784 | ||||||
|
Gain on sale of asset
|
(37,835 | ) | (74,564 | ) | ||||
|
Deferred rent adjustment
|
(9,236 | ) | 8,705 | |||||
|
Changes in assets and liabilities:
|
||||||||
|
Accounts receivable
|
664,945 | (586,354 | ) | |||||
|
Inventories
|
(67,735 | ) | (17,085 | ) | ||||
|
Prepaid
expenses and other assets
|
(213,040 | ) | (125,222 | ) | ||||
|
Accounts payable
|
(143,092 | ) | 27,286 | |||||
|
Accrued expenses
|
110,443 | 17,700 | ||||||
|
Deferred revenue
|
4,812 | 115,863 | ||||||
|
Net
cash used in operating activities
|
270,658 | (321,560 | ) | |||||
|
Cash flows from investing activities
|
||||||||
|
Sale of equipment
|
40,103 | 79,038 | ||||||
|
Purchase of property and equipment
|
(498,636 | ) | (134,742 | ) | ||||
|
Development of patents
|
(6,117 | ) | (13,285 | ) | ||||
|
Net cash used in investing activities
|
(464,650 | ) | (68,989 | ) | ||||
|
Cash flows from financing activities
|
||||||||
|
Borrowings on long-term debt
|
1,000,000 | - | ||||||
|
Payments made on long term debt
|
(200,001 | ) | (200,001 | ) | ||||
|
Net borrowings on line of credit
|
(709,229 | ) | 356,833 | |||||
|
Net cash provided by financing activities
|
90,770 | 156,832 | ||||||
|
Net decrease in cash and cash equivalents
|
(103,222 | ) | (233,717 | ) | ||||
|
Cash and cash equivalents, beginning of the year
|
269,548 | 251,087 | ||||||
|
Cash and cash equivalents, end of period
|
$ | 166,326 | $ | 17,370 | ||||
| Page 3 |
|
March 31,
|
December 31,
|
|||||||
|
2014
|
2013
|
|||||||
|
Work-in-progress
|
$ | 77,811 | $ | 77,997 | ||||
|
Finished goods
|
908,477 | 840,556 | ||||||
| $ | 986,288 | $ | 918,553 | |||||
| Page 4 |
| Page 5 |